eMERGE is a national network organized and funded by the National Human Genome Research Institute (NHGRI) that combines DNA biorepositories with electronic medical record (EMR) systems for large scale, high-throughput genetic research in support of implementing genomic medicine.
Many factors contribute to risk of a disease. Some of these factors are internal, like genetics, and others are external, like where someone lives. Over the last several years researchers have discovered that in addition to one gene being associated with a given disease (monogenic factors), many genes across your genome can contribute to the development of a disease (polygenic factors). To learn more about elements that contribute to risk a disease, click here.
Latest News
ACMG 3.0 List Released
May 5, 2021 3:17 PM
NIH Office of Data Science Strategy Releases Four Notices of Special Interest that Address Workforce/Strategic Gaps in Artificial Intelligence/Machine Learning
April 4, 2021 8:57 PM
Invitae to partner with eMERGE as a clinical affiliate to investigate monogenic risk of conditions
April 4, 2021 4:58 PM
Dr. Lori Orlando 2021 PROSE Award Recognition
March 3, 2021 1:11 PM
Lessons Learned from eMERGE III
January 1, 2021 3:53 PM
NHGRI announces the next round of the eMERGE Network
July 7, 2020 2:19 PM
Recent Publications
Satterfield BA, Dikilitas O, Kullo IJ. Leveraging the Electronic Health Record to Address the COVID-19 Pandemic. Mayo Clinic proceedings. 2021 Jun;96(6):1592-1608.
Rasmussen LV, Connolly JJ, Del Fiol G, Freimuth RR, Taylor CO, et al. Infobuttons for Genomic Medicine: Requirements and Barriers. Applied clinical informatics. 2021 Mar;12(2):383-390.
Chang X, Li Y, Nguyen K, Qu H, Hakonarson H. Genetic correlations between COVID-19 and a variety of traits and diseases. Innovation (New York, N.Y.). 2021 May 28;2(2):100112.